Evolocumab “must become cheaper” to be cost effective in enhancing benefits of statins

Evolocumab, a cholesterol lowering drug that may enhance the benefits of statins, will need to be sold at a much lower price to be cost effective, two studies have found, but they disagree on how...

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2vExdpd
via IFTTT